Literature DB >> 23952325

The pathophysiology of venous hypertensive myelopathy--study of an animal model: laboratory investigation.

Hong-Qi Zhang1, Tong Chen, Shao-Shuai Wu, Liang-Hong Teng, Yong-Zhong Li, Li-Yong Sun, Zhi-Ping Zhang, De-Yu Guo, De-Hong Lu, Feng Ling.   

Abstract

OBJECT: The authors undertook this study to establish an animal model to investigate the pathophysiological changes of venous hypertensive myelopathy (VHM).
METHODS: This study was a randomized control animal study with blinded evaluation. The VHM model was developed in 24 adult New Zealand white rabbits by means of renal artery and vein anastomosis and trapping of the posterior vena cava; 12 rabbits were subjected to sham surgery. The rabbits were investigated by spinal function evaluation, abdominal aortic angiography, spinal MRI, and pathological examination of the spinal cord at different follow-up stages.
RESULTS: Twenty-two (91.67%) of 24 model rabbits survived the surgery and postoperative period. The patency rate of the arteriovenous fistula was 95.45% in these 22 animals. The model rabbits had significantly decreased motor and sensory hindlimb function as well as abnormalities at the corresponding segments of the spinal cord. Pathological examination showed dilation and hyalinization of the small blood vessels, perivascular and intraparenchymal lymphocyte infiltration, proliferation of glial cells, and neuronal degeneration. Electron microscopic examination showed loose lamellar structure of the myelin sheath, increased numbers of mitochondria in the thin myelinated fibers, and pyknotic neurons.
CONCLUSIONS: This model of VHM is stable and repeatable. Exploration of the sequential changes in spinal cord and blood vessels has provided improved understanding of this pathology, and the model may have potential for improving therapeutic results.

Entities:  

Mesh:

Year:  2013        PMID: 23952325     DOI: 10.3171/2013.6.SPINE11860

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  3 in total

1.  Venous disruption affects white matter integrity through increased interstitial fluid in cerebral small vessel disease.

Authors:  Ruiting Zhang; Peiyu Huang; Yeerfan Jiaerken; Shuyue Wang; Hui Hong; Xiao Luo; Xiaopei Xu; Xinfeng Yu; Kaicheng Li; Qingze Zeng; Xiao Wu; Min Lou; Minming Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2020-02-16       Impact factor: 6.200

2.  Potential biomarkers of spinal dural arteriovenous fistula: C4BPA and C1QA.

Authors:  Yinqing Wang; Yongjie Ma; Chengbin Yang; Hongqi Zhang; Xiahe Huang; Kun Yang; Fei Lan; Jingxuan Fu; Zihao Song; An Tian; Yueshan Feng; Tianqi Tu; Haifeng Li; Tao Hong; Yingchun Wang
Journal:  J Neuroinflammation       Date:  2022-06-22       Impact factor: 9.587

3.  Long-term outcomes and prognostic factors in patients with treated spinal dural arteriovenous fistulas: a prospective cohort study.

Authors:  Chengbin Yang; Yongjie Ma; An Tian; Jiaxing Yu; Sichang Chen; Chao Peng; Kun Yang; Guilin Li; Chuan He; Ming Ye; Tao Hong; Lisong Bian; Zhichao Wang; Feng Ling; Hongqi Zhang
Journal:  BMJ Open       Date:  2022-01-03       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.